Development and Testing of ImHere4U: a Digital Suicide Prevention Intervention for Cyberbullied Adolescents
Launched by UNIVERSITY OF PITTSBURGH · Aug 15, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new digital program called Flourish, which aims to help teenagers who have been bullied online and may be feeling very sad or having thoughts of suicide. The researchers want to see if using Flourish, along with some questionnaires, is more helpful than just answering the questionnaires alone. They will be working with about 80 teenagers aged 12 to 17, especially focusing on those from underserved backgrounds. Participants will be asked to engage with the program over six months and share their experiences to see if it helps them feel better and cope with their feelings.
To be eligible for this study, participants need to be English-speaking, have access to a phone or device for texting, and must have experienced cyberbullying and some level of psychological distress or suicidal thoughts in the past three months. The researchers will keep track of how many people join and stay in the study, as well as how much they engage with the Flourish program. Participants can expect to receive support through this digital program, and they may also have the option to share their social media experiences for additional feedback. This trial is currently recruiting participants, so if you or someone you know fits the criteria, it might be a good opportunity to get help.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • English-speaking
- • access to a phone or device capable of text messaging
- • past 3-month history of cyberbullying assessed by the cybervictimization subscale of the Traditional Bullying and Cyberbullying Victimization and Perpetration Scale and/or presence of online discrimination measured by a modified version of a discrimination measured developed as part of the Adolescent Brain and Cognitive Development (ABCD) study
- • past 3-month history of suicidal risk, including: psychological distress (\>13 on the 6-item Kessler Psychological Distress Scale) and/or suicidal ideation or behavior (via the Columbia Suicide Severity Rating Scale)
- Exclusion Criteria:
- • intellectual challenges, low literacy levels, or other conditions that might inhibit adolescents' ability to effectively engage with Flourish (reported by parents and, if needed, confirmed through the age-appropriate Wechsler Intelligence scale)
- • acuity levels suggesting need for a higher level of care (e.g., inpatient hospitalization) or referral for emergency services
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Candice L Biernesser, PhD
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported